Abstract
1. Imipramine and its oxidized metabolites 2-hydroxyimipramine, desmethylimipramine (DMI), 2-hydroxydesmethylimipramine (2-OH-DMI), didesmethylimipramine (DDMI) and iminodibenzyl (IDB) all interact with cytochrome P-450 to give rise to the type I spectral change when added to suspensions of rat liver microsomes.2. Imipramine, DMI and the more polar 2-OH-DMI, all exhibit high affinities for binding to the cytochrome.3. The magnitude of the type I spectral change produced by imipramine is not enhanced by the further addition of DMI, neither is the DMI-induced type I spectral change increased by 2-OH-DMI. Thus it appears that imipramine and its oxidized metabolites interact with a common cytochrome P-450 species and that the inhibitory effect of DMI and 2-OH-DMI on the oxidation of imipramine and DMI, respectively, may be due to competition for binding to cytochrome P-450.4. At low concentrations DDMI elicits a type I spectral change with microsomes but with increased concentration produces a type II spectra...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Xenobiotica; the fate of foreign compounds in biological systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
